Despite Canopy Growth quarterly results, Canadian cannabis names not trading much lower

Aug. 05, 2022 12:42 PM ETTilray Brands, Inc. (TLRY), ACB, CGC, CRONOGI, CRON:CA, TLRY:CA, ACB:CABy: Jonathan Block, SA News Editor21 Comments

Medical Oil Cannabis - marijuana oil, resin and flowers with Canada flag on the mirror black background.


  • Even though Canopy Growth Corp. (NASDAQ:CGC) reported fiscal 2022 Q1 results that saw its net loss widen and revenue decline leading to a 8% decline on Friday, other Canadian cannabis companies  are not seeing as big of a drop.
  • In early Friday afternoon trading, Tilray Brands (NASDAQ:TLRY) is down 2.6%, Aurora Cannabis (NASDAQ:ACB-2%, Cronos Group (NASDAQ:CRON-1.2%, Sundial Growers -0.6%, and OrganiGram Holdings (OGI-0.5%.
  • The sector has had a tough year so far. The New Cannabis Ventures Canadian Cannabis LP Index is down 51% year to date. Canopy Growth is down ~72% over that period.
  • Seeking Alpha's Quant Rating views Canopy Growth (CGC) as a hold with an "F" for momentum.

Recommended For You

Comments (21)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.